We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ONCT market cap is 25.88M. The company's latest EPS is USD -13.3391 and P/E is -0.66.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 382k | 171k | 203k | 106k | 179k |
| Operating Income | -11.33M | -11.92M | -12.14M | -9.55M | -10.39M |
| Net Income | -11.13M | -11.4M | -11.49M | -8.97M | -9.86M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.43M | 3.38M | 4.32M | 1.49M | 785k |
| Operating Income | -33.11M | -17.54M | -31.37M | -44.95M | -41.71M |
| Net Income | -34.19M | -17.23M | -31.33M | -44.17M | -39.48M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 76.17M | 68.65M | 58.28M | 50.77M | 43.2M |
| Total Liabilities | 7.63M | 7.68M | 5.79M | 5.59M | 6.2M |
| Total Equity | 68.54M | 60.97M | 52.49M | 45.18M | 37M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 21.74M | 118.81M | 93.59M | 68.65M | 36.73M |
| Total Liabilities | 7.43M | 5.86M | 5.47M | 7.68M | 6.68M |
| Total Equity | 14.31M | 112.95M | 88.12M | 60.97M | 30.05M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -27.7M | -36.7M | -10.97M | -20.23M | -25.75M |
| Investing | N/A | -26.5M | -16.05M | -2.2M | 2.46M |
| Financing | 7.57M | 9.58M | 1.12M | 1.12M | 1.07M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -16.75M | -17.5M | -26.59M | -36.7M | -32.16M |
| Investing | 16.14M | N/A | N/A | -26.5M | 651k |
| Financing | 15k | 114.18M | 617k | 9.58M | 1.07M |
| Market Cap | 25.88M |
| Price to Earnings Ratio | -0.66 |
| Price to Sales Ratio | 32.96 |
| Price to Cash Ratio | 3.86 |
| Price to Book Ratio | 0.86 |
| Dividend Yield | - |
| Shares Outstanding | 2.96M |
| Average Volume (1 week) | 4.26k |
| Average Volume (1 Month) | 6.34k |
| 52 Week Change | 29.75% |
| 52 Week High | 13.14 |
| 52 Week Low | 5.5656 |
| Spread (Intraday) | 69.11 (89.63%) |
| Company Name | Oncternal Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.oncternal.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
